Joseph Vittiglio
General Counsel chez BLUEBIRD BIO, INC.
Fortune : 60 039 $ au 31/03/2024
Profil
Joseph D.
Vittiglio currently works at American Cancer Society, Inc., as Director, Casa Monte Cassino, Inc, as Director, The Lynnfield Youth Soccer Club, as Director, bluebird bio, Inc., as Chief Business & Legal Officer from 2023, and Gaffin & Krattenmaker PC, as Associate Attorney.
Mr. Vittiglio also formerly worked at Oscient Pharmaceuticals Corp., as Director-Corporate Legal Affairs from 2005 to 2007, AMAG Pharma USA, Inc., as Secretary, Flexion Therapeutics, Inc., as Vice President-Legal Affairs & General Counsel in 2015, Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC, as Senior Associate from 1998 to 2005, AVEO Pharmaceuticals, Inc., as Secretary, Senior Vice President & General Counsel from 2014 to 2015, AMAG Pharmaceuticals, Inc., as Secretary, Chief Business Officer & Executive VP in 2020, and Finch Therapeutics Group, Inc., as Secretary, Chief Business & Legal Officer from 2021 to 2022.
Mr. Vittiglio received his undergraduate degree from Tufts University and graduate degree in 1996 from Northeastern University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0,02% | 01/03/2024 | 44 783 ( 0,02% ) | 57 322 $ | 31/03/2024 |
| 10/04/2023 | 1 045 ( 0,07% ) | 2 717 $ | 31/03/2024 |
Postes actifs de Joseph Vittiglio
| Sociétés | Poste | Début |
|---|---|---|
| BLUEBIRD BIO, INC. | General Counsel | 03/01/2023 |
| Casa Monte Cassino, Inc | Director/Board Member | 06/04/2011 |
| The Lynnfield Youth Soccer Club | Director/Board Member | 06/04/2011 |
| Gaffin & Krattenmaker PC | Corporate Officer/Principal | - |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Director/Board Member | - |
Anciens postes connus de Joseph Vittiglio
| Sociétés | Poste | Fin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | General Counsel | 31/12/2022 |
| AMAG PHARMACEUTICALS, INC. | General Counsel | 16/11/2020 |
| FLEXION THERAPEUTICS, INC. | General Counsel | 01/08/2015 |
| AVEO PHARMACEUTICALS, INC. | General Counsel | 19/03/2015 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Joseph Vittiglio
| Tufts University | Undergraduate Degree |
| Northeastern University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Entreprise privées | 10 |
|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| Casa Monte Cassino, Inc | |
| The Lynnfield Youth Soccer Club | |
| Gaffin & Krattenmaker PC |
